Cytoplasmic RNA Sensor Pathways and Nitazoxanide Broadly Inhibit Intracellular Mycobacterium tuberculosis Growth

Summary To establish stable infection, Mycobacterium tuberculosis (MTb) must overcome host innate immune mechanisms, including those that sense pathogen-derived nucleic acids. Here, we show that the host cytosolic RNA sensing molecules RIG-I-like receptor (RLR) signaling proteins RIG-I and MDA5, their common adaptor protein MAVS, and the RNA-dependent kinase PKR each independently inhibit MTb growth in human cells. Furthermore, we show that MTb broadly stimulates RIG-I, MDA5, MAVS, and PKR gene expression and their biological activities. We also show that the oral FDA-approved drug nitazoxanide (NTZ) significantly inhibits intracellular MTb growth and amplifies MTb-stimulated RNA sensor gene expression and activity. This study establishes prototypic cytoplasmic RNA sensors as innate restriction factors for MTb growth in human cells and it shows that targeting this pathway is a potential host-directed approach to treat tuberculosis disease.

[1]  Bin Wu,et al.  Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition , 2011, Proceedings of the National Academy of Sciences.

[2]  Yong Cheng,et al.  Mycobacterium tuberculosis–induced IFN-β production requires cytosolic DNA and RNA sensing pathways , 2018, The Journal of experimental medicine.

[3]  E. Rubin,et al.  HIV-1 Replication Is Differentially Regulated by Distinct Clinical Strains of Mycobacterium tuberculosis , 2009, PloS one.

[4]  H. Einolf,et al.  Evaluation of Clinical Drug Interaction Potential of Clofazimine Using Static and Dynamic Modeling Approaches , 2018, Drug Metabolism and Disposition.

[5]  J. V. Falvo,et al.  A Role for IFITM Proteins in Restriction of Mycobacterium tuberculosis Infection , 2015, Cell reports.

[6]  Jeff S. Schorey,et al.  Extracellular vesicles deliver Mycobacterium RNA to promote host immunity and bacterial killing , 2019, EMBO reports.

[7]  B. Pantenburg,et al.  Treatment of cryptosporidiosis , 2009, Expert review of anti-infective therapy.

[8]  C. Rice,et al.  ATP-dependent effector-like functions of RIG-I-like receptors. , 2015, Molecular cell.

[9]  William E. Ortyn,et al.  Cellular image analysis and imaging by flow cytometry. , 2007, Clinics in laboratory medicine.

[10]  Zhijian J. Chen,et al.  Cyclic GMP-AMP Synthase Is an Innate Immune DNA Sensor for Mycobacterium tuberculosis. , 2015, Cell host & microbe.

[11]  T. Clark,et al.  Primary macrophages and J774 cells respond differently to infection with Mycobacterium tuberculosis , 2017, Scientific Reports.

[12]  O. Elroy-Stein,et al.  Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 alpha-specific protein kinase. , 1993, The Journal of biological chemistry.

[13]  E. Barros,et al.  Renal tuberculosis in the modern era. , 2013, The American journal of tropical medicine and hygiene.

[14]  J. Parrillo,et al.  JAK kinases are required for the bacterial RNA and poly I:C induced tyrosine phosphorylation of PKR. , 2013, International journal of clinical and experimental medicine.

[15]  Q. Wen,et al.  Different Signaling Pathways Define Different Interferon-Stimulated Gene Expression during Mycobacteria Infection in Macrophages , 2019, International journal of molecular sciences.

[16]  I. Kerr,et al.  Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon , 1990, Cell.

[17]  Michael B. Brenner,et al.  Regulation of Tumor Necrosis Factor Alpha Gene Expression by Mycobacteria Involves the Assembly of a Unique Enhanceosome Dependent on the Coactivator Proteins CBP/p300 , 2003, Molecular and Cellular Biology.

[18]  P. Hipskind,et al.  In Vitro Evaluation of Novel Nitazoxanide Derivatives against Mycobacterium tuberculosis , 2017, ACS omega.

[19]  C. Nathan,et al.  Efficacy of Nitazoxanide against Clinical Isolates of Mycobacterium tuberculosis , 2013, Antimicrobial Agents and Chemotherapy.

[20]  M. Curran,et al.  Nitazoxanide , 2012, Drugs.

[21]  J. V. Falvo,et al.  Arc of a vicious circle: pathways activated by Mycobacterium tuberculosis that target the HIV-1 long terminal repeat. , 2011, American journal of respiratory cell and molecular biology.

[22]  V. Hornung,et al.  Cytosolic RNA:DNA hybrids activate the cGAS–STING axis , 2014, The EMBO journal.

[23]  Stanley N Cohen,et al.  Improved Control of Tuberculosis and Activation of Macrophages in Mice Lacking Protein Kinase R , 2012, PloS one.

[24]  Shizuo Akira,et al.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.

[25]  Wenting Zhu,et al.  An autoinhibitory mechanism modulates MAVS activity in antiviral innate immune response , 2015, Nature Communications.

[26]  L. D. de Carvalho,et al.  Nitazoxanide Disrupts Membrane Potential and Intrabacterial pH Homeostasis of Mycobacterium tuberculosis. , 2011, ACS medicinal chemistry letters.

[27]  R. Lins,et al.  Pharmacokinetics of nitazoxanide after single oral dose administration in 6 healthy volunteers. , 1996, International journal of clinical pharmacology and therapeutics.

[28]  J. Puglisi,et al.  The anti-hepatitis C agent nitazoxanide induces phosphorylation of eukaryotic initiation factor 2alpha via protein kinase activated by double-stranded RNA activation. , 2009, Gastroenterology.

[29]  Jonathan L. Schmid-Burgk,et al.  The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING-Cell Death Program Upstream of NLRP3 , 2017, Cell.

[30]  Ho-Yeon Song,et al.  Lack of Activity of Orally Administered Clofazimine against Intracellular Mycobacterium tuberculosis in Whole-Blood Culture , 2004, Antimicrobial Agents and Chemotherapy.

[31]  J. Cui,et al.  Mechanisms and pathways of innate immune activation and regulation in health and cancer , 2014, Human vaccines & immunotherapeutics.

[32]  M. Berg,et al.  The multiple faces of proteinkinase R in antiviral defense , 2013, Virulence.

[33]  L. D. de Carvalho,et al.  Nitazoxanide kills replicating and nonreplicating Mycobacterium tuberculosis and evades resistance. , 2009, Journal of medicinal chemistry.

[34]  A. Goldfeld,et al.  Treatment of drug-resistant tuberculosis among people living with HIV , 2018, Current opinion in HIV and AIDS.

[35]  T. Walz,et al.  RIG-I forms signaling-competent filaments in an ATP-dependent, ubiquitin-independent manner. , 2013, Molecular cell.

[36]  Zhijian J. Chen,et al.  MAVS Forms Functional Prion-like Aggregates to Activate and Propagate Antiviral Innate Immune Response , 2011, Cell.

[37]  Karen K. Y. Lam,et al.  Nitazoxanide Stimulates Autophagy and Inhibits mTORC1 Signaling and Intracellular Proliferation of Mycobacterium tuberculosis , 2012, PLoS pathogens.

[38]  Cheng-Zhong Zhang,et al.  Breaching Self-Tolerance to Alu Duplex RNA Underlies MDA5-Mediated Inflammation , 2018, Cell.

[39]  M. Cooper,et al.  Synthesis and pre-clinical studies of new amino-acid ester thiazolide prodrugs , 2016, European Journal of Medicinal Chemistry.

[40]  J. Rossignol Nitazoxanide: A first-in-class broad-spectrum antiviral agent , 2014, Antiviral Research.

[41]  A. Pichlmair,et al.  Discrimination of Self and Non-Self Ribonucleic Acids. , 2017, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[42]  S. Akira,et al.  Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors. , 2014, Cold Spring Harbor perspectives in biology.

[43]  Natasha S. Barteneva,et al.  Imaging flow cytometry analysis of intracellular pathogens. , 2017, Methods.

[44]  V. Hornung,et al.  cGAS Senses Human Cytomegalovirus and Induces Type I Interferon Responses in Human Monocyte-Derived Cells , 2016, PLoS pathogens.

[45]  D. Hockenbery,et al.  Inhibition of vaccinia virus replication by nitazoxanide. , 2018, Virology.

[46]  N. Grishin,et al.  Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response. , 2012, Immunity.

[47]  M. Katze,et al.  Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA-activated, 68,000-Mr protein kinase in a cell-free system , 1991, Molecular and cellular biology.

[48]  P. Bevilacqua,et al.  Mechanistic Analysis of Activation of the Innate Immune Sensor PKR by Bacterial RNA. , 2015, Journal of molecular biology.

[49]  A. Goldfeld,et al.  Regulation of Mycobacterium tuberculosis-Dependent HIV-1 Transcription Reveals a New Role for NFAT5 in the Toll-Like Receptor Pathway , 2012, PLoS pathogens.

[50]  A. Pichlmair,et al.  RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates , 2006, Science.

[51]  S. Vogel,et al.  Space and time: New considerations about the relationship between Toll-like receptors (TLRs) and type I interferons (IFNs). , 2015, Cytokine.

[52]  Jinwei Zhang,et al.  The search for a PKR code—differential regulation of protein kinase R activity by diverse RNA and protein regulators , 2019, RNA.

[53]  Osamu Takeuchi,et al.  IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction , 2005, Nature Immunology.

[54]  R. Vance,et al.  Identification of Host Cytosolic Sensors and Bacterial Factors Regulating the Type I Interferon Response to Legionella pneumophila , 2009, PLoS pathogens.

[55]  P. Bevilacqua,et al.  Discriminating Self and Non-Self by RNA: Roles for RNA Structure, Misfolding, and Modification in Regulating the Innate Immune Sensor PKR. , 2016, Accounts of chemical research.

[56]  Ralf Bartenschlager,et al.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.

[57]  Y. Modis,et al.  MDA5 cooperatively forms dimers and ATP‐sensitive filaments upon binding double‐stranded RNA , 2012, The EMBO journal.

[58]  S. Kaufmann,et al.  Inflammation in tuberculosis: interactions, imbalances and interventions. , 2013, Current opinion in immunology.

[59]  P. Pierre,et al.  Integration of PKR‐dependent translation inhibition with innate immunity is required for a coordinated anti‐viral response , 2015, FEBS letters.

[60]  C. Samuel,et al.  The PKR kinase promoter binds both Sp1 and Sp3, but only Sp3 functions as part of the interferon-inducible complex with ISGF-3 proteins. , 2003, Virology.

[61]  W. Bishai,et al.  A bacterial cyclic dinucleotide activates the cytosolic surveillance pathway and mediates innate resistance to tuberculosis , 2015, Nature Medicine.

[62]  D. Rosillon,et al.  Nitazoxanide pharmacokinetics and tolerability in man during 7 days dosing with 0.5 g and 1 g b.i.d. , 2002, International journal of clinical pharmacology and therapeutics.

[63]  E. Kurbatova,et al.  Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters , 2017, The Journal of antimicrobial chemotherapy.

[64]  Z. Zhai,et al.  VISA Is an Adapter Protein Required for Virus-Triggered IFN-β Signaling , 2005 .

[65]  D. Portnoy,et al.  Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveillance pathway within macrophages. , 2012, Cell host & microbe.

[66]  J. Hiscott,et al.  Crosstalk between Cytoplasmic RIG-I and STING Sensing Pathways. , 2017, Trends in immunology.

[67]  Zhijian J. Chen,et al.  Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I , 2014, Nature.

[68]  S. Hur,et al.  How RIG-I like receptors activate MAVS. , 2015, Current opinion in virology.

[69]  Jonathan L. Schmid-Burgk,et al.  Mycobacterium tuberculosis Differentially Activates cGAS- and Inflammasome-Dependent Intracellular Immune Responses through ESX-1. , 2015, Cell host & microbe.

[70]  M. Esteban,et al.  Interferon inhibits Viral Protein Synthesis in L Cells infected with Vaccinia Virus , 1972, Nature.

[71]  Y. Lau,et al.  A Role for Double-Stranded RNA-Activated Protein Kinase PKR in Mycobacterium-Induced Cytokine Expression1 , 2005, The Journal of Immunology.

[72]  S. Akira,et al.  Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid–inducible gene-I and melanoma differentiation–associated gene 5 , 2008, The Journal of experimental medicine.

[73]  T. Walz,et al.  Structural Basis for dsRNA Recognition, Filament Formation, and Antiviral Signal Activation by MDA5 , 2013, Cell.

[74]  Jonathan L. Schmid-Burgk,et al.  OutKnocker: a web tool for rapid and simple genotyping of designer nuclease edited cell lines , 2014, Genome research.

[75]  H. Virgin,et al.  The Cytosolic Sensor cGAS Detects Mycobacterium tuberculosis DNA to Induce Type I Interferons and Activate Autophagy. , 2015, Cell host & microbe.

[76]  P. Hunter,et al.  Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis. , 2007, British journal of clinical pharmacology.

[77]  M. Hayakari,et al.  Critical Role of IRF-3 in the Direct Regulation of dsRNA-Induced Retinoic Acid-Inducible Gene-I (RIG-I) Expression , 2016, PloS one.

[78]  A. Sher,et al.  Type I interferons in tuberculosis: Foe and occasionally friend , 2018, The Journal of experimental medicine.

[79]  D. Siegler,et al.  Pulmonary tuberculosis , 1951 .

[80]  V. Hornung,et al.  cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING , 2013, Nature.

[81]  C. Samuel,et al.  Mechanism of interferon action: evidence for intermolecular autophosphorylation and autoactivation of the interferon-induced, RNA-dependent protein kinase PKR , 1993, Journal of virology.

[82]  P. Escalante Tuberculosis , 1904, Annals of Internal Medicine.

[83]  G. Hartmann,et al.  RIG‐I detects infection with live Listeria by sensing secreted bacterial nucleic acids , 2012, The EMBO journal.

[84]  Olaf Wolkenhauer,et al.  Diagnostic Potential of Imaging Flow Cytometry. , 2018, Trends in biotechnology.

[85]  Jonathan L. Schmid-Burgk,et al.  Antiviral activity of human OASL protein is mediated by enhancing signaling of the RIG-I RNA sensor. , 2014, Immunity.

[86]  C. Nathan,et al.  Evidence for dispensability of protein kinase R in host control of tuberculosis , 2018, European journal of immunology.

[87]  Y. Modis,et al.  Pattern Recognition and Signaling Mechanisms of RIG-I and MDA5 , 2014, Front. Immunol..

[88]  C. Prinz,et al.  Extracellular and intracellular pattern recognition receptors cooperate in the recognition of Helicobacter pylori. , 2009, Gastroenterology.

[89]  P. Penczek,et al.  Molecular imprinting as a signal-activation mechanism of the viral RNA sensor RIG-I. , 2014, Molecular cell.

[90]  W. Boom,et al.  Activity of nitazoxanide and tizoxanide against Mycobacterium tuberculosis in vitro and in whole blood culture. , 2016, Tuberculosis.

[91]  M. Tatematsu,et al.  Extracellular RNA Sensing by Pattern Recognition Receptors , 2018, Journal of Innate Immunity.

[92]  John L. Johnson,et al.  Whole blood bactericidal activity during treatment of pulmonary tuberculosis. , 2003, The Journal of infectious diseases.

[93]  K. Ishii,et al.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.

[94]  F. Giannoni,et al.  Activities of Drug Combinations against Mycobacterium tuberculosis Grown in Aerobic and Hypoxic Acidic Conditions , 2013, Antimicrobial Agents and Chemotherapy.

[95]  T. Butters,et al.  Nitazoxanide, an antiviral thiazolide, depletes ATP-sensitive intracellular Ca(2+) stores. , 2014, Virology.

[96]  S. Fortune,et al.  Requirement for Invariant Chain in Macrophages for Mycobacterium tuberculosis Replication and CD1d Antigen Presentation , 2011, Infection and Immunity.

[97]  S. Bavari,et al.  The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus , 2019, iScience.

[98]  Anand Kumar,et al.  Bacterial RNA induces myocyte cellular dysfunction through the activation of PKR. , 2012, Journal of thoracic disease.

[99]  S. Goodbourn,et al.  The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[100]  K. Rosenblum,et al.  PKR: A Kinase to Remember , 2019, Front. Mol. Neurosci..

[101]  T. Kawai,et al.  Discrimination Between Self and Non-Self-Nucleic Acids by the Innate Immune System , 2018, International Review of Cell and Molecular Biology.

[102]  Shizuo Akira,et al.  Shared and Unique Functions of the DExD/H-Box Helicases RIG-I, MDA5, and LGP2 in Antiviral Innate Immunity1 , 2005, The Journal of Immunology.

[103]  A. Hovanessian,et al.  Autophosphorylation of the protein kinase dependent on double-stranded RNA. , 1987, The Journal of biological chemistry.

[104]  Gunther Hartmann,et al.  5'-Triphosphate RNA Is the Ligand for RIG-I , 2006, Science.

[105]  Zhijian J. Chen,et al.  Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3 , 2005, Cell.

[106]  T. Moran,et al.  Cytokine-Independent Upregulation of MDA5 in Viral Infection , 2007, Journal of Virology.